2,0
5 mrt 2025
Voormalige werknemer
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht
Pluspunten
Novel blood test that helps neurologists objectively manage patients with MS.
Minpunten
New leadership puts their goal of receiving next level funding/revenue over patient care. Drove cost of the test up by 500% for MS patients that already had difficulty affording the test. Tarnished relationships with providers and their staff.